Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms.
Acta Haematol
; 144(1): 48-57, 2021.
Article
in En
| MEDLINE
| ID: mdl-32160610
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Decitabine
/
Myeloproliferative Disorders
/
Antimetabolites, Antineoplastic
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Acta Haematol
Year:
2021
Type:
Article
Affiliation country:
United States